Trial Profile
Clinical Endpoint Therapeutic Equivalence Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%; Alvogen Pine Brook LLC.) to Estrace® Cream (0.01%; Warner Chilcott) in Postmenopausal Females With Atrophic Vaginitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Dec 2021
Price :
$35
*
At a glance
- Drugs Estradiol (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- Sponsors Alvogen
- 19 Dec 2016 New trial record